Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies
- Conditions
- Epilepsies, MyoclonicDrug Resistant Epilepsy
- Registration Number
- NCT04457687
- Lead Sponsor
- Eisai Inc.
- Brief Summary
The primary purpose of this study is to provide continued access of lorcaserin to participants with Dravet syndrome and other refractory epilepsies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
- Confirmed diagnosis of Dravet syndrome (according to Recommendation from a North American Consensus Panel, 2017) or other refractory epilepsy (per the judgment of the treating physician)
- Male or female, age at least 2 years at the time of informed consent
- Currently treated with lorcaserin, that the treatment is for Dravet syndrome or other refractory epilepsies, and the treatment was initiated before 13 Feb 2020; or has completed Study E2023-A001-304
- Has a clinical benefit from lorcaserin in the opinion of the treating physician
None
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (22)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
David Geffen School of Medicine, UCLA Mattel Children's Hospital
🇺🇸Los Angeles, California, United States
Children's Hospital Colorado
🇺🇸Aurora, Colorado, United States
Pena
🇺🇸Avon, Connecticut, United States
(Resor)
🇺🇸Greenwich, Connecticut, United States
Children's National Medical Center
🇺🇸Washington, District of Columbia, United States
Clinical Neurosciences of Tampa Bay
🇺🇸Clearwater, Florida, United States
Miami Children's Hospital - Nicklaus Children's Hospital Miami
🇺🇸Miami, Florida, United States
Mid-Atlantic Epilepsy and Sleep Center - Bethesda
🇺🇸Bethesda, Maryland, United States
University of Missouri Health Care
🇺🇸Columbia, Missouri, United States
Scroll for more (12 remaining)University of Alabama at Birmingham🇺🇸Birmingham, Alabama, United States